NOX 14.3% 8.0¢ noxopharm limited

Impact of COVID-19 on clinical trials, page-15

  1. 102 Posts.
    lightbulb Created with Sketch. 27
    Lets hope NOX discontinues to spend money on Covid-19 research/trials. Pfizer have had their magic pill pushed straight to the front of the defence line. From what I understand they have bypassed clinical trials and booked in to meet with FDA November 30th. Pfizer's board of directors include Scott Gottlieb. He stepped down from his position as FDA Commissioner in April 2019 to join Pfizer. Though I doubt that has any thing to do with Pfizer getting their vaccine and soon to be approved PF-07321332 pill through the FDA door. People have renamed the pill "Pfizermectrin".......
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.010(14.3%)
Mkt cap ! $23.37M
Open High Low Value Volume
7.0¢ 8.0¢ 7.0¢ $4.207K 56.02K

Buyers (Bids)

No. Vol. Price($)
1 118527 7.5¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 4999 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.